The Bangladesh National Tuberculosis Control Program (NTP), in partnership with USAID through the TB CARE II project, recently published a set of guidelines meant to assist in the diagnosis and management of TB in children.
DOTS represents the best strategy for coordinating TB services within the broader health system, mobilizing wide support
at the operational level, reducing TB incidence, and preventing further drug resistance.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a global partnership of researchers, caregivers, and advocates who have come together to end the neglect of this vulnerable population of children. The project team collaborates to develop and deploy evidence-based strategies to prevent the death of children from this treatable disease; it is a learning network committed to generating and disseminating knowledge and data for immediate action.
In 2011-2012, TB CARE II undertook a study to understand TB patients’ delays and inform the development of an integrated set of recommendations for TB program managers and service providers regarding the appropriateness of different strategies for reducing patient factor delays in accessing TB diagnostic and treatment services.
To support the National Tuberculosis Program (NTP) of Indonesia in its efforts to train private health care practitioners in tuberculosis (TB) directly observed treatment, the USAID Health Care Improvement Project was asked by USAID to update and adapt for Indonesia a computer-based training product that had previously been developed for Bolivia by the USAID-funded Quality Assurance Project.In collaboration with the NTP, the Indonesian Medical Association (Ikatan Dokter Indonesia, or IDI), the Indonesian Midwife Association (IBI), and the Indonesian National Nurses Association (PPN
The Quality Assurance Project commissioned a rapid assessment of the Bangladesh service delivery system for TB-DOTS, the internationally recommended strategy for tuberculosis control. The assessment was designed to inform the development of a context-specific strategy to ensure the delivery of high-quality TB-DOTS care to achieve sustained detection of 70% of new smear-positive patients and an 85% cure rate.
The reduction of the default rate among patients with tuberculosis (TB) in Metro Manila is presented. An intervention study was performed among 239 patients with TB, aged 12-84 years. All TB service providers were given instructions and practice in the use of flip chart and the patient and health care system contract. Consequently, the patients with systematic pattern of drug collection for at least 10 weeks were counted as compliers. Anyone who began the treatment but did not continue for at least 10 weeks was counted as default of treatment.
In 2006, USAID/Bolivia asked the Quality Assurance Project (QAP) to work with its bilateral health project, Gestión y Calidad en Salud (GCS) and the National TB Control Program (NTP) of the Ministry of Health (MOH) to implement an improvement collaborative aimed at strengthening the TB program’s performance.
This report presents reflections on South African supporters of DOTS, the internationally recommended strategy for tuberculosis (TB) control. The DOTS strategy has been implemented on a national level in South Africa's fight against TB, and DOTS supporters are lay health workers who provide some of the services called for by the strategy. The report draws on qualitative data from the Western Cape metropolitan area and the Nyandeni district of the Eastern Cape.
This is the sixteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ﬁnancing TB prevention, care and control at global, regional and country levels using data reported by 198 countries that account for over 99% of the world’s TB cases.
The Global Plan to Stop TB 2011–2015: Transforming the Fight—Towards Elimination of Tuberculosis, released by the STOP TB Partnership in Oct 2010, updates the Global Plan to Stop TB 2006-2015 and sets new and more ambitious targets. The new plan identifies all the research gaps that need to be filled to bring rapid TB tests, faster treatment regimens and a fully effective vaccine to market.